We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Randox Licenses sPLA2 CVD Risk Test from Aterovax

Product News   May 02, 2013

 
Randox Licenses sPLA2 CVD Risk Test from Aterovax
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Owlstone Medical Announces Key Study Results on Use of Breath Biopsy for Improved Detection of Liver Disease Including NASH and NAFLD

Product News

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath biomarker to measure liver function and stage liver disease.

READ MORE

Genomic Leaders To Create Australia’s First National COVID-19 Tracking System

Product News

Illumina announced today that the Australian public health laboratories will aim to sequence the virus genomes of all positive COVID-19 tests in Australia and track COVID-19 using genomics across the country, rather than state by state, under a ground-breaking initiative spearheaded by Australia’s public health laboratory organisations and leading industry partners.

READ MORE

Aigenpulse Launches Data Analysis Suite To Automate Flow Cytometry

Product News

Life science and data technology innovator, Aigenpulse, is launching its CytoML Experiment Suite – an automated, end-to-end, machine learning solution specifically aimed at streamlining and automating cytometry analysis at scale and replacing manual gating processes.

READ MORE

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE